查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
遙測心電圖設備全球市場-2022-2029
市場調查報告書
商品編碼
1140676

遙測心電圖設備全球市場-2022-2029

Global ECG Telemetry Devices Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

家庭監控設備將引領市場增長。

對家庭護理監測設備的需求將會增加，從而減少醫院進行心臟檢查的成本和時間。對於心血管疾病等危及生命的疾病，定期心臟檢查很重要，而家庭護理監測設備則更容易。因此，這些設備有助於遙測心電圖設備市場的增長。

此外，心血管疾病發病率和患病率的增加正在推動市場增長。在過去的二十年裡，高收入國家的心血管和其他心臟病死亡人數有所下降，但在低收入和中等收入國家卻以驚人的速度增加。據世界衛生組織稱，大約 80.0% 的心血管疾病死亡發生在非洲、拉丁美洲和亞太地區等低收入和中等收入地區。在北美，心肌梗死死亡率受多種因素驅動，包括藥物洗脫支架、經皮冠狀動脈成形術的增加以及主要不良心血管疾病一級和二級預防的循證藥物持續下降。

按地區劃分的流行率。

北美將是預測期內的主要地區。

在預測期內，北美市場將以最大的份額引領全球遙測心電設備市場。心血管疾病是美國的主要死亡原因，也是急症護理住院日和就診的主要原因。根據美國疾病控制和預防中心 (CDC) 的數據，心血管疾病在美國每年造成約 610,000 人死亡，佔死亡人數的近四分之一。因此，美國對心電遙測設備的需求相當準確，這推動了該地區尤其是美國的市場增長。

此外，預計亞太地區在預測期內將以全球最高的複合年增長率增長。這一增長歸因於政府在醫院、計算機化和基礎設施方面的舉措增加。亞太地區現有的醫療保健基礎設施仍在開發中，包括印度、中國、日本和澳大利亞。發展中地區開發新型遙測心電圖設備的潛力巨大。全球約一半的心血管疾病負擔由亞太地區承擔。因此，大量患者表明遙測心電圖設備市場的迫切需求。

競爭格局。

心電圖遙測設備市場由少數公司主導。 Aerotel Medical Systems Ltd.、BioTelemetry Inc.、GE Healthcare、Medtronic Plc、iRhythm Technologies Inc.、Nihon Kohden、Philips Healthcare 和 Medicalgorithmics SA 等公司是市場增長的關鍵參與者。主要參與者正在執行多項增長戰略，例如產品發布、收購和合作夥伴關係，據估計這些戰略將推動全球遙測心電圖設備市場。 2022 年 3 月，GE Healthcare 宣布與 HIMSS 的 AliveCor 建立合作夥伴關係，以推出一個新的數字平台。我們將在奧蘭多全球健康會議暨展覽會上發布兩項重大公告。第一個公告是關於開發利用人工智能的數位健康平台。另一項宣布是與總部位於加利福尼亞州山景城的 AliveCor 建立合作夥伴關係，這將允許從醫療設備製造商的心電圖儀中獲取的心電圖直接進入 GE Healthcare 的 MUSE 心臟管理系統。 2022 年 4 月，GE Healthcare 和美敦力宣布合作，以滿足日益增長的門診護理需求。該合作夥伴關係為客戶提供了廣泛的產品組合、金融解決方案和卓越的服務。

COVID-19 的影響。它將對遙測心電圖設備的全球市場產生負面影響。

隨著 COVID-19 大流行席捲全球多個地區，在全球遙測心電圖設備市場運營的公司擁有良好的前景。預計這些供應商將加快生產步伐，以滿足對遙測心電圖設備不斷增長的需求。最近，對用於監測 COVID-19 的新技術的投資有所增加。這為在全球遙測 ECG 設備市場上運營的公司提供了廣闊的發展空間。此外，遙測心電圖設備市場的主要參與者正專注於開發定制設備，用於對 COVID-19 患者進行基本監測。

內容

第 1 章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

  • 按產品劃分的市場細分
  • 按應用劃分的市場細分
  • 按地區劃分的市場細分

第 4 章市場動態

  • 市場影響因素
  • 促進因素
    • 心血管疾病高發
    • 新興國家的醫療保健支出增加
    • 遠程監控技術的技術進步
  • 抑制因素
    • 複雜的報銷政策
  • 商機
  • 影響分析

第 5 章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 價值鏈分析
  • PEST 分析
  • 定價分析
  • 監管分析
  • 保險報銷分析
  • 未滿足的需求
  • 專利趨勢

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品分類

  • 事件監測、MCT（移動心臟遙測）
  • 其他

第 8 章按應用程序

  • 心律失常
  • 心肌缺血/心肌梗塞
  • 起搏器監測
  • 其他

第 9 章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 10 章競爭格局

  • 競爭場景
  • 市場定位/市場份額分析
  • 併購分析

第 11 章公司簡介

  • Aerotel Medical Systems Ltd.
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • BioTelemetry Inc.
  • GE Healthcare
  • Medtronic Plc
  • iRhythm Technologies Inc.
  • Nihon Kohden Corporation
  • Philips Healthcare
  • Medicalgorithmics SA
  • Preventice Solutions Inc.
  • Hill-Rom Services Inc.（Welch Allyn）
  • Other Companies

第 12 章數據M

簡介目錄
Product Code: DMHCIT3000

Market Overview

ECG telemetry devices market was valued at USD XX million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of 8 % during the forecast period (2022-2029).

ECG device monitors and records the electrical movement of the heart. It detects and gathers electrical impulses generated by the polarization and depolarization of cardiac tissue and translates them into a waveform. It helps physicians or cardiologists diagnose cardiac abnormalities and the size and position of chambers. This technique detects cardiac abnormalities and analyzes the effects of drugs or devices used to regulate the heart. The ECG telemetry device can detect complex dysrhythmias and myocardial ischemia. The ECG telemetry devices market is driving due to the growing government interventions to reform the healthcare sector. Moreover, technological advances and increasing government interventions to render quality medical devices at affordable prices for miniature and telemetry devices have grown significantly in the past couple of years.

Market Dynamics: Home monitoring devices lead the market's growth.

Homecare monitoring devices' demand increases, reducing the cost and time taken in hospitals for heart checkups. For life-threatening diseases, such as cardiovascular disorders, regular checkup of the heart is crucial, and it is made easy by homecare monitoring devices. Hence, these devices are helping the ECG telemetry devices market to grow.

Also, the Increasing incidence and prevalence of cardiovascular diseases drive market growth. Over the past two decades, fatalities due to cardiovascular disease and other heart diseases have been declining in high-income countries; however, they have been rising at an alarming rate in lower and middle-income countries. Around 80.0% of the mortalities caused due to CVD occur in low-middle income group regions, such as Africa, Latin America, and Asia-Pacific, as per the WHO. In North America, myocardial infarction fatality is continuously decreasing due to several factors, such as drug-eluting stents, increasing adoption of percutaneous coronary angioplasty, and evidence-based medications for primary and secondary prevention of major adverse cardiovascular diseases.

Market Segmentation: Event monitoring and MCT (Mobile Cardiac Telemetry) segment accounted for the highest share in global ECG telemetry devices market.

The event monitoring and MCT (Mobile Cardiac Telemetry) segment are anticipated to dominate the market with the largest value share. Mobile cardiac telemetry is the most modern of the monitoring options. MCT devices are small portable monitors that automatically send data when a cardiac anomaly is detected. It is superior to other forms of ambulatory cardiac monitoring (Holter or Event Monitoring); therefore, its demand is expected to rise in the ECG telemetry device market during the forecast period.

By application, the ECG telemetry devices market is classified into arrhythmia, myocardial ischemia and infarction, pacemaker monitoring, and others. In terms of application, the arrhythmia segment is expected to dominate the global ECG telemetry devices market during the forecast period. In arrhythmia, the heart rhythm functions abnormally, wherein the electrical impulses either occur too fast or too slow, leading to the reduced proficiency of the heart to pump blood. There are various devices used in arrhythmias diagnosis. The ECG telemetry devices are one of the most efficient tools to detect arrhythmias. According to a World Health organization estimation data, the aged population above 60 years and over increased in 2020. By 2050, the aged population above 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. As this population is more prone to cardiovascular diseases such as arrhythmias, the demand for ECG telemetry devices to diagnose arrhythmia is expected to impact the market positively.

Geographical Penetration: North America is the dominating region during the forecast period.

During the forecast period, the North American market leads with the largest share in the global ECG telemetry devices market. Cardiovascular diseases are the primary cause of mortality in the U.S. and the major cause of acute hospital bed days and physician visits. According to the Centers for Disease Control and Prevention (CDC), about 610,000 mortalities are registered due to cardiovascular diseases in the U.S. every year, which accounts for almost one in every four fatalities. Therefore, the demand for ECG telemetry devices is considerably accurately high in the U.S., which drives the market growth in the region, especially in the U.S.

Moreover, the Asia Pacific region is expected to grow at the highest CAGR globally during the forecast period. This growth is due to the increased government initiatives on hospitals, computerization, and infrastructure. The existing healthcare infrastructure in the Asia-Pacific countries such as India, China, Japan, and Australia is still in progress. Significant prospects exist for developing novel ECG telemetric devices in developing regions. Approximately half of the burden of the world of CVD is carried by the Asia-Pacific region. Therefore, the large patient population indicates an imminent need for the ECG telemetry device market.

Competitive Landscape:

The ECG telemetry devices market is dominated by a few companies. Key players in the market's growth include Aerotel Medical Systems Ltd., BioTelemetry Inc., GE Healthcare, Medtronic Plc, iRhythm Technologies Inc., Nihon Kohden Corporation, Philips Healthcare, and Medicalgorithmics SA, among others. The key players execute several growth strategies, such as product launches, acquisitions, and collaborations, which are estimated to boost the global ECG telemetry devices market. In March 2022, GE Healthcare announced a partnership with AliveCor to launch a new digital platform at HIMSS. The company made two major announcements at the Orlando Global Health Conference & Exhibition. The company's first announcement is the development of an AI-enabled digital health platform. And another announcement is about a partnership with Mountain View, California-based AliveCor, through which electrocardiogram readings taken on the medical device company's EKG device will be delivered directly into GE Healthcare's MUSE Cardiac Management System. In April 2022, GE Healthcare and Medtronic Announced a Collaboration to Meet the Growing Need for Outpatient Care. Under this collaboration, customers accessed extensive product portfolios, financial solutions, and exceptional service.

COVID-19 Impact: Negative impact on the global ECG Telemetry Devices market.

The companies operating in the global ECG telemetry devices market have a good prospect at their disposal as the COVID-19 pandemic grips several parts worldwide. These vendors are expected to accelerate their manufacturing pace to meet the expanding demand for ECG telemetry devices. Investments in novel technologies used to monitor COVID-19 have increased in recent times. It has offered a large playfield of advancement for the companies operating in the global ECG telemetry devices market. Furthermore, the ECG telemetry devices market's leading players focus on developing custom-made devices to monitor the fundamentals of COVID-19 patients.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
  • 4.2. Drivers
    • 4.2.1. The high incidence rate of cardiovascular diseases
    • 4.2.2. Improved spending on healthcare in emerging markets
    • 4.2.3. Technological Advancements in Remote Monitoring Technologies
  • 4.3. Restraints:
    • 4.3.1. Complex Reimbursement Policies
  • 4.4. Opportunity
  • 4.5. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
  • 7.3. Market Attractiveness Index, By Product Segment
    • 7.3.1. Event Monitoring and MCT (Mobile Cardiac Telemetry)
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Others

8. By Application

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 8.3. Market Attractiveness Index, By Application Segment
    • 8.3.1. Arrhythmias*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Myocardial Ischemia and Infarction
    • 8.3.3. Pacemaker Monitoring
    • 8.3.4. Others

9. By Region

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 9.3. Market Attractiveness Index, By Region
  • 9.4. North America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. The U.S.
      • 9.4.5.2. Canada
      • 9.4.5.3. Mexico
  • 9.5. Europe
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. Germany
      • 9.5.5.2. The U.K.
      • 9.5.5.3. France
      • 9.5.5.4. Italy
      • 9.5.5.5. Spain
      • 9.5.5.6. Rest of Europe
  • 9.6. South America
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.6.5.1. Brazil
      • 9.6.5.2. Argentina
      • 9.6.5.3. Rest of South America
  • 9.7. Asia Pacific
    • 9.7.1. Introduction
    • 9.7.2. Key Region-Specific Dynamics
    • 9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.7.5.1. China
      • 9.7.5.2. India
      • 9.7.5.3. Japan
      • 9.7.5.4. Australia
      • 9.7.5.5. Rest of Asia Pacific
  • 9.8. The Middle East and Africa
    • 9.8.1. Introduction
    • 9.8.2. Key Region-Specific Dynamics
    • 9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Aerotel Medical Systems Ltd.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. BioTelemetry Inc.
  • 11.3. GE Healthcare
  • 11.4. Medtronic Plc
  • 11.5. iRhythm Technologies Inc.
  • 11.6. Nihon Kohden Corporation
  • 11.7. Philips Healthcare
  • 11.8. Medicalgorithmics SA
  • 11.9. Preventice Solutions Inc.
  • 11.10. Hill-Rom Services Inc. (Welch Allyn)
  • 11.11. Other Companies

12. DataM Intelligence

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us